1. Home
  2. PSA vs ZTS Comparison

PSA vs ZTS Comparison

Compare PSA & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Public Storage

PSA

Public Storage

HOLD

Current Price

$303.16

Market Cap

51.8B

Sector

Real Estate

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$74.50

Market Cap

49.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSA
ZTS
Founded
1972
1952
Country
United States
United States
Employees
5770
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.8B
49.7B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
PSA
ZTS
Price
$303.16
$74.50
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$310.08
$154.18
AVG Volume (30 Days)
931.1K
6.0M
Earning Date
04-27-2026
05-07-2026
Dividend Yield
4.08%
1.86%
EPS Growth
N/A
10.05
EPS
N/A
1.42
Revenue
N/A
$9,467,000,000.00
Revenue This Year
$2.84
$5.63
Revenue Next Year
$5.55
$4.77
P/E Ratio
$33.19
$54.13
Revenue Growth
N/A
2.28
52 Week Low
$256.54
$75.11
52 Week High
$313.51
$172.23

Technical Indicators

Market Signals
Indicator
PSA
ZTS
Relative Strength Index (RSI) 51.87 11.94
Support Level $274.73 N/A
Resistance Level $313.11 $129.32
Average True Range (ATR) 6.73 3.45
MACD -0.09 -4.53
Stochastic Oscillator 54.14 0.25

Price Performance

Historical Comparison
PSA
ZTS

About PSA Public Storage

Public Storage is the largest owner of self-storage facilities in the US, with more than 3,500 self-storage facilities in 40 states and approximately 258 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage. The company also has a merchandise business, a third-party property management business, and an insurance business that offers products to cover losses for the goods in self-storage facilities.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: